At least $8,311 in Medicaid payments were made in Monsey in 2024 for services billed through HCPCS codes specifically linked to COVID-19, data from the U.S. Department of Health and Human Services Medicaid Provider Spending database show.
Medicaid is a public health insurance system, operated by the states and backed by both federal and state governments. It provides coverage for low-income individuals and families, seniors, children, and people with disabilities, making it one of the nation’s largest health care programs.
Medicaid spending relies on public funds, so shifts in local billing numbers show how community resources for public health care are distributed.
This analysis uses HCPCS codes labeled or described as “COVID-19” or “coronavirus”-related to identify COVID-19 services. Therefore, these totals only include services directly labeled as COVID-related in billing data and omit pandemic-linked care billed under broader or varied medical codes.
For context, Brooklyn led the state in total Medicaid payments for COVID-19 services in 2024, with $3,718,101 in virus-related claims.
In Monsey, four providers filed Medicaid claims for COVID-related services in 2024. The Immunoassay code was among the most frequently billed, totaling $5,042.
To provide perspective, the average Medicaid payment per provider for COVID-19–related services in Monsey equaled $2,078, which is below the state average of $29,403.
During the pandemic years, Medicaid spending growth in Monsey included a significant portion tied to COVID-19–specific services.
Total Medicaid payments for all other claim categories rose by $36,448,697 from 2020 to 2024, marking a 33.1% rise.
In the two years before the pandemic, Monsey’s average annual Medicaid payments were $82,271,681.
Data from the Centers for Medicare & Medicaid Services estimates combined state and federal Medicaid spending at about $871.7 billion in fiscal year 2023, accounting for about 18% of national health spending—a substantial increase from $613.5 billion in 2019, prior to the COVID-19 outbreak.
This 40% increase is attributed primarily to broadening enrollment and greater service utilization during and after the pandemic period.
Legislation enacted under the Trump administration recently included major proposals to shrink federal Medicaid funding and modify the program’s structure. The “One Big Beautiful Bill Act,” signed into law in 2025, is anticipated to reduce federal Medicaid spending by more than $1 trillion over 10 years and features measures such as work requirements and added cost-sharing that could decrease coverage and funding for some recipients. These policy shifts are expected to push more financial responsibility to states and diminish the expansion of federal support for Medicaid, as the program continues to cover tens of millions of U.S. residents.
| Year | COVID-19–Related Payments | COVID-19 Payments % Change (YoY) | Total Medicaid Payments |
|---|---|---|---|
| 2024 | $8,311 | -99.9% | $146,613,986 |
| 2023 | $7,307,968 | -77.1% | $177,736,174 |
| 2022 | $31,910,200 | 248.7% | $204,856,084 |
| 2021 | $9,151,376 | 8,006% | $136,822,292 |
| 2020 | $112,896 | N/A | $110,269,873 |
| 2019 | $0 | N/A | $89,130,234 |
| 2018 | $0 | N/A | $75,413,128 |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 87811 | Immunoassay | $5,042 | 744 |
| 87635 | COVID Specific | $3,270 | 149 |
Note: Includes HCPCS codes explicitly labeled for COVID-19 services; totals do not represent all pandemic-related health care spending.
This article uses information from the U.S. Department of Health and Human Services Medicaid Provider Spending database. Source data is available here.










